EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1

Yizhi Cao, Xuelong Wang, Yang Liu, Pengyi Liu, Jiejie Qin, Youwei Zhu, Shuyu Zhai, Yongsheng Jiang, Yihao Liu, Lijie Han, Jiaxin Luo, Ronghao Zhang und 13 weitere

Advanced Science · 2024-02 · 11 (7)

DOI: 10.1002/advs.202306298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.12.2023. Verfasst von Yizhi Cao und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, P. R. C…. Hauptthemen laut MEDLINE: Ferroptosis, Pancreatic Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Nature Science Foundation of China, Shanghai International Scientific Cooperation Project, Frontier Project of the Shanghai Hospital Development Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer (PCa) is one of the most fatal human malignancies. The enhanced infiltration of stromal tissue into the PCa tumor microenvironment limits the identification of key tumor‐specific transcription factors and epigenomic abnormalities in malignant epithelial cells. Integrated transcriptome and epigenetic multiomics analyses of the paired PCa organoids indicate that the basic helix‐loop‐helix transcription factor 40 (BHLHE40) is significantly upregulated in tumor samples. Increased chromatin accessibility at the promoter region and enhanced mTOR pathway activity contribute to the elevated expression of BHLHE40. Integrated analysis of chromatin immunoprecipitation‐seq, RNA‐seq, and high‐throughput chromosome conformation capture data, together with chromosome conformation capture assays, indicate that BHLHE40 not only regulates sterol regulatory element‐binding factor 1 (SREBF1) transcription as a classic transcription factor but also links the enhancer and promoter regions of SREBF1. It is found that the BHLHE40‐SREBF1‐stearoyl‐CoA desaturase axis protects PCa cells from ferroptosis, resulting in the reduced accumulation of lipid peroxidation. Moreover, fatostatin, an SREBF1 inhibitor, significantly suppresses the growth of PCa tumors with high expressions of BHLHE40. This study highlights the important roles of BHLHE40‐mediated lipid peroxidation in inducing ferroptosis in PCa cells and provides a novel mechanism underlying SREBF1 overexpression in PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisPancreatic NeoplasmsHumansHomeodomain ProteinsTranscription FactorsBasic Helix-Loop-Helix ProteinsTumor MicroenvironmentSterol Regulatory Element Binding Protein 1

Stichwörter der Autor:innen

BHLHE40SREBF1ferroptosislipid peroxidationpancreatic cancer

Substanzen

Homeodomain ProteinsTranscription FactorsBasic Helix-Loop-Helix ProteinsSterol Regulatory Element Binding Protein 1BHLHE40 protein, humanSREBF1 protein, human

Autor:innen und Institutionen

  • Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, P. R. China.
  • Research Institute of Pancreatic Diseases, Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, P. R. China.
  • State Key Laboratory of Oncogenes and Related Genes, Institute of Translational Medicine, Shanghai Jiaotong University, Shanghai, 200025, P. R. China.
  • Institute of Translational Medicine, Shanghai Jiaotong University, Shanghai, 200025, P. R. China.
  • Shanghai Key Laboratory of Pancreatic Neoplasms Translational Medicine, Shanghai, 200025, P. R. China.

ORCID-Profile: Baiyong Shen

Förderung

  • National Nature Science Foundation of China
  • Shanghai International Scientific Cooperation Project
  • Frontier Project of the Shanghai Hospital Development Center
  • National Natural Science Foundation of China

Zitieren

APA

Cao, Y., Wang, X., Liu, Y., Liu, P., Qin, J., Zhu, Y., Zhai, S., Jiang, Y., Liu, Y., Han, L., Luo, J., Zhang, R., Shi, M., Wang, L., Tang, X., Xue, M., Liu, J., Wang, W., Wen, C., …, & Shen, B. (2024). BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. Advanced Science, 11(7). https://doi.org/10.1002/advs.202306298

Vancouver

Cao Y, Wang X, Liu Y, Liu P, Qin J, Zhu Y, et al. BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. Advanced Science. 2024;11(7). doi:10.1002/advs.202306298

BibTeX
@article{Cao2024,
  author = {Cao, Yizhi and Wang, Xuelong and Liu, Yang and Liu, Pengyi and Qin, Jiejie and Zhu, Youwei and Zhai, Shuyu and Jiang, Yongsheng and Liu, Yihao and Han, Lijie and Luo, Jiaxin and Zhang, Ronghao and Shi, Minmin and Wang, Liwen and Tang, Xiaomei and Xue, Meilin and Liu, Jia and Wang, Weishen and Wen, Chenlei and Deng, Xiaxing and Peng, Chenghong and Chen, Hao and Cheng, Dongfeng and Jiang, Lingxi and Shen, Baiyong},
  title = {BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {7},
  doi = {10.1002/advs.202306298}
}
Kostenlos starten →